Open AccessRebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients
Author(s) -
Schnell Bianca R.,
Seipel Katja,
Bacher Ulrike,
Jeker Barbara,
Mueller Beatrice U.,
Banz Yara,
Novak Urban,
Pabst Thomas
Publication year - 2019
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000180
Subject(s) - medicine , platelet , myeloid leukemia , thrombopoietin , induction chemotherapy , electron paramagnetic resonance , thrombopoietin receptor , megakaryocyte , oncology , chemotherapy , immunology , cancer research , haematopoiesis , biology , stem cell , physics , nuclear magnetic resonance , genetics
Supplemental Digital Content is available in the text